Folcyteine Tablet
FDA Label NDC 59088-795

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Puretek Corporation for the product Folcyteine (NDC 59088-795). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description:, other ingredients:, indications and usage:, contraindications:, warnings:, precautions, adverse reactions:, dosage and administration:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Warnings:

Tell your doctor if you have: kidney problems, thyroid disease. This medication should be used as directed during pregnancy or while breast-feeding. Consult your doctor. Administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient.

* Please review the disclaimer below.